Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correlations between in vivo tumor weight, oxygen pressure, 31P NMR spectroscopy, hypoxic microenvironment marking by beta-D-iodinated azomycin galactopyranoside (beta-D-IAZGP), and radiation sensitivity.
Saitoh J, Sakurai H, Suzuki Y, Muramatsu H, Ishikawa H, Kitamoto Y, Akimoto T, Hasegawa M, Mitsuhashi N, Nakano T. Saitoh J, et al. Among authors: hasegawa m. Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):903-9. doi: 10.1016/s0360-3016(02)03013-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12377344
Attenuation of chronic thermotolerance by KNK437, a benzylidene lactam compound, enhances thermal radiosensitization in mild temperature hyperthermia combined with low dose-rate irradiation.
Sakurai H, Kitamoto Y, Saitoh J, Nonaka T, Ishikawa H, Kiyohara H, Shioya M, Fukushima M, Akimoto T, Hasegawa M, Nakano T. Sakurai H, et al. Among authors: hasegawa m. Int J Radiat Biol. 2005 Sep;81(9):711-8. doi: 10.1080/09553000500448172. Int J Radiat Biol. 2005. PMID: 16368649
A prospective study of reduced-dose three-course CHOP followed by involved-field radiotherapy for patients 70 years old or more with localized aggressive non-Hodgkin's lymphoma.
Shikama N, Oguchi M, Isobe K, Nakamura K, Tamaki Y, Hasegawa M, Kodaira T, Sasaki S, Kagami Y; Japan Radiation Oncology Group (JAROG). Shikama N, et al. Among authors: hasegawa m. Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):217-22. doi: 10.1016/j.ijrobp.2006.04.006. Epub 2006 Jul 11. Int J Radiat Oncol Biol Phys. 2006. PMID: 16814951 Clinical Trial.
Initial experience with the quality assurance program of radiation therapy on behalf of Japan Radiation Oncology Group (JAROG).
Isobe K, Kagami Y, Higuchi K, Kodaira T, Hasegawa M, Shikama N, Nakazawa M, Fukuda I, Nihei K, Ito K, Teshima T, Oguchi M; Japan Radiation Oncology Group (JAROG). Isobe K, et al. Among authors: hasegawa m. Jpn J Clin Oncol. 2007 Feb;37(2):135-9. doi: 10.1093/jjco/hyl129. Epub 2007 Jan 25. Jpn J Clin Oncol. 2007. PMID: 17255160 Free article.
A multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG).
Isobe K, Kagami Y, Higuchi K, Kodaira T, Hasegawa M, Shikama N, Nakazawa M, Fukuda I, Nihei K, Ito K, Teshima T, Matsuno Y, Oguchi M; Japan Radiation Oncology Group. Isobe K, et al. Among authors: hasegawa m. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1181-6. doi: 10.1016/j.ijrobp.2007.04.029. Epub 2007 Jul 2. Int J Radiat Oncol Biol Phys. 2007. PMID: 17601683 Clinical Trial.
4,132 results